Cipla DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.74×	0.77×	0.73×	0.70×
	1.11×	1.12×	1.13×	1.09×	1.05×
	12.4%	16.6%	21.9%	20.3%	16.9%
	0.71×	0.71×	0.79×	0.83×	0.80×
	1.22×	1.23×	1.19×	1.22×	1.24×
	8.8%	12.0%	18.1%	16.3%	12.4%
	11.8%	11.8%	18.2%	16.5%	12.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CIPLA₹1,325.70

Cipla Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA DRREDDY LUPIN APOLLOHOSP MAXHEALTH DIVISLAB TORNTPHARM ZYDUSLIFEMcap ₹1.07L Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.70	0.73	0.77	0.74	0.74
Interest Burden (Pretax/EBIT) ×	1.05	1.09	1.13	1.12	1.11
EBIT Margin %	16.94	20.33	21.86	16.59	12.37
Asset Turnover ×	0.80	0.83	0.79	0.71	0.71
Financial Leverage (Assets/Equity) ×	1.24	1.22	1.19	1.23	1.22
ROE (5-step product, year-end total equity) %	12.38	16.33	18.06	11.99	8.80
ROE (owners' profit / average owners' equity) %	12.66	16.45	18.21	11.82	11.82

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.